Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kringle Pharma Inc.

www.kringle-pharma.com

Latest From Kringle Pharma Inc.

Asia Beat: Japan's bioventure sector needs decisive action

Japan has been attempting to get its bioventure sector off the ground for as long as many in the industry can remember, certainly since I first started coming to the country more than 20 years ago. But progress continues to be glacially slow.

Cancer Orthopedics

Scrip Asia 100 - Asia's shining stars

The Scrip Asia 100 analysis identifies 100 of the most influential players on the Asia-Pacific life sciences scene. Our shining stars are 10 of Asia's visionary leaders from the worlds of pharma business and science.

Dermatology Immune Disorders

Europe venture to take on Kringle's lead project

Kringle Pharma has set up its first overseas operation, a European subsidiary which will progress the clinical development of its lead recombinant hepatic growth factor therapy.

Dermatology Wound Healing & Tissue Repair

Tripep turns to Japanese partner for trial funding

Cash-strapped Tripep has secured funding for a new clinical trial of a recombinant hepatocyte growth factor (HGF) therapy from its partner for the product, the Japanese bioventure Kringle Pharma.

Dermatology Gynecology & Urology
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Kringle Pharma Inc.
  • Senior Management
  • Kunio Iwatani, Pres. & CEO
    Kiichi Adachi, PhD, EVP, Dir., Bus. Dev.
    Keigo Hanada, DVM, PhD, Dir., R&D
  • Contact Info
  • Kringle Pharma Inc.
    Phone: (81)
    8F Senri Asahi Hankyu, Bldg.1-5-3
    Toyonaka
    Shinsenri-Higashimachi, 560-0082
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register